CSX Corp. (CSX - Free Report) is one of the big American railroads. It reported strong earnings for the first quarter which beat the Zacks Consensus Estimate by 11 cents. Analysts are bullish and raising estimates for the full year. Earnings are expected to grow in the double digits this year and next. CSX is trading more like a technology stock than an old railroad. Shares are up 26% year-to-date and have a 20-year return of over 1500%. CSX is a Zacks Rank #2 (Buy).
BioTelemetry (BEAT - Free Report) is a healthcare innovator in the remote medical technology category, especially in the heart area. It has teamed up with Apple in collecting heart data. Shares are down 7% year-to-date and now trade with a forward P/E of just 28. The company reports earnings on Apr 25. It’s a Zacks Rank #1 (Strong Buy).
Should these three companies be on your investing short list? Find out in this week’s video.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>